Leishmaniasis, Mucocutaneous - 7 Studies Found
| Completed | 
                                    : Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis : Leishmaniasis, Mucocutaneous : 2005-05-20 : Biological: Leish-111f + MPL-SE vaccine  | 
                                
| Completed | 
                                    : Low Antimonial Dosage in American Mucosal Leishmaniasis : 
  | 
                                
| Completed | 
                                    : Miltefosine to Treat Mucocutaneous Leishmaniasis : 
 : 2010-01-12 : Drug: miltefosine 2.5 mg/kg/day for 28 days  | 
                                
| Available | 
                                    : Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis : 
 : Drug: sodium stibogluconate (Pentostam) 20 mg/kg IV every day for 20 or 28 days  | 
                                
| Completed | 
                                    : Miltefosine for Mucosal Leishmaniasis : Leishmaniasis : 2006-09-07 : Drug: miltefosine 2.5 mg/kg/day for 28 days  | 
                                
| Completed | 
                                    : Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis : Leishmaniasis : 2006-09-07 : Drug: miltefosine: 2.5 mg/kg/day for 42 days  | 
                                
| Not yet recruiting | 
                                    : Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia : 
  |